Learn Mode

PGNY - Progyny Inc

61

$17.27

-$0.52 (-2.923%)

At market close

$17.28

$0.005 (0.029%)

After Hours 3/27/26, 8:34 PM

3.85/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

PGNY

Valuation Score

View as %

Stock Unlock

1D

1W

1M

YTD

1Y

3Y

5Y

Max

Stock Profile

Market Cap

$1.41B

Industry

Health Care

EPS (TTM)

$0.65

P/E (TTM)

24.17

Div & Yield

--

FCF Payout Ratio

--

P/S (TTM)

1.10

P/B

2.74

Diluted Shares

89.79M

Ex-Dividend

--

Next Earnings

05-06

Forward P/E

13.22

Payout Ratio

--

P/FCF (TTM)

7.38

FCF Yield

13.56%

Earnings Yield

4.14%

52 Week Range

Score Card

Explore Scores Tab

3.85

Good

Progyny Inc has grown revenue at 10.4% over the past year, which is strong growth. Also, it has more cash than liabilities meaning it could use its current cash position to be completely debt-free, if it wanted to.

Valuation Model

Key Score

4.00

Good

Management

4.00

Good

Growth

2.00

Bad

Profitability

3.00

Average

Fin. Health

3.00

Average

Dividends

--

--

Analyst

1.00

Very Bad

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-27 11:19:23

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-19 17:12:56

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-13 16:15:27

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:36:37

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:35:02

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 17:32:38

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 17:32:14

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 17:31:56

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 17:31:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 17:30:50

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-04 12:00:41

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-03 14:59:40

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$37.80

118.9%

Avg:

$30.79

78.3%

Low:

$26.26

52.1%

(% change is relative to the current stock price: $17.27)

Analyst Recommendations

Go to Analyst Tab

4.18

Good

35%

Strong Buy (6)

47%

Buy (8)

18%

Hold (3)

0%

Sell (0)

0%

Strong Sell (0)

About

Website
https://www.progyny.com/
Address
1359 Broadway, 2Nd Floor, New York City NEW YORK, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1551306

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 856 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

IPO Date

2019-10-25

Industry

Health Care

Total Employees

856

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Health Care Providers & Services

GICS Sub

Managed Health Care

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services